Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has data to warrant grabbing a headline slot at the upcoming ASH haematology ...
Penny Gusner is a senior insurance writer and analyst at Forbes Advisor. For more than 20 years, she has been helping consumers learn how insurance laws, data, trends, and coverages affect them. Penny ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback